SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense trading activity as market participants speculate on a potential acquisition by major tech players like Amazon, following reports of ongoing buyout talks that have triggered a massive surge in volume. The community is actively debating the implications of this possible deal, contrasting the potential buyout premium against current market valuations while weighing the company's critical role in satellite connectivity and its long-standing partnership with Apple.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is in the spotlight as investors anticipate the upcoming Artemis II mission, which marks the first crewed deep-space flight in over 50 years. The community is actively debating the stock's long-term potential within the lunar economy while closely monitoring technical price levels and market-wide volatility driven by geopolitical tensions.

Launchr is a programmable creator fee engine designed to adapt to every stage of a token’s lifecycle.  Instead of hard coded splits or one time choices, Launchr lets creators dynamically route fees in real time based on market conditions, liquidity depth, and strategy.

Launchr

Investors are actively debating the viability and longevity of the token amidst high-energy launch promotion and community efforts to drive trading volume. While some participants focus on the excitement of early-stage momentum, others are voicing caution regarding the sustainability of these types of market movements.

nCino, Inc. engages in the provision of cloud-based software applications for financial institutions in the United States and internationally. Its nCino Bank Operating System, a tenant cloud platform, digitizes, automates, and streamlines complex processes and workflow, and utilizes data analytics and artificial intelligence and machine learning (AI/ML) to enable financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposit and other accounts, and manage regulatory compliance. The firm's nCino IQ is an application suite that utilizes data analytics and AI/ML to provide its customers with automation and insights into their operations, such as tools for analyzing, measuring, and managing credit risk, as well as to enhance their ability to comply with regulatory requirements. The company was founded by Pierre Naudé in 2011 and is headquartered in Wilmington, NC.

Ncino Inc.

nCino is currently in focus following a significant expansion of its stock repurchase program, which has fueled positive community sentiment regarding the company's long-term capital allocation strategy. Investors and analysts are actively debating the stock's valuation after strong earnings performance and management's focus on accelerating growth in its cloud banking and AI-driven product offerings.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz Global Holdings Inc

Hertz is currently at the center of a tug-of-war between retail traders anticipating a turnaroundfueled by speculation of increased institutional involvement, potential short squeeze setups, and seasonal travel tailwindsand skeptics highlighting significant debt and earnings volatility. The community remains heavily focused on monitoring call flow and technical indicators, with intense debate over whether current price levels offer a deep-value opportunity or if the stock remains trapped by structural headwinds.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is seeing heightened volatility as retail traders speculate on a potential short squeeze, frequently comparing its low float and share structure to past parabolic meme stock runs. While some community members anticipate a massive rally based on historical spikes, others warn of significant downside risk, characterizing the activity as a high-stakes pump and dump involving extreme borrowing fees.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is gaining attention as investors digest new contract awards and the company's expanding role in national security and NASA lunar missions. The community is actively debating the impact of ongoing insider selling by private equity firms against the stock's long-term potential in the growing space and defense sectors.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is capturing significant investor interest as the community reacts to a confirmed launch window for the BlueBird-7 satellite, serving as a critical catalyst after recent price volatility. Discussions are heavily focused on the stock's long-term infrastructure potential versus the risks of execution delays, with investors debating whether to treat recent pullbacks as prime accumulation opportunities ahead of broader sector growth.

iShares Trust - iShares U.S. Treasury Bond ETF

iShares U.S. Treasury Bond ETF

Investors are actively debating the role of GOVT and broader Treasury ETFs amid concerns over rising national debt, shifting Federal Reserve rate expectations, and increased foreign buying of U.S. government debt. Market participants are split between using these bonds as a defensive hedge against potential economic volatility and warning that current yield levels may not sufficiently compensate for long-term fiscal risks.

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals is trending as investors monitor the company's progress in expanding its obesity treatment pipeline, particularly following positive trial data and regulatory milestones for its core asset, IMCIVREE. The community remains focused on the potential for strategic M&A activity and the clinical success of upcoming candidates targeting hypothalamic obesity, which many see as a major value-driving catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tilray Brands (NASDAQ:TLRY) Trading Down 5.1% - Here's Why

Tilray Brands (NASDAQ:TLRY) Stock Price Down 5.1% - Should You Sell...

Tariff uncertainty has prompted several analysts to cut their price targets for Five9 stock. 

RYM Stock Surges 45%, Breaches 100-DMA For First Time In Over Three Months – What Triggered This Rally?

Rythm announced amendments to its licensing agreements with Green Thumb, under which it would be paid a fixed annual cash fee of $70 million.

Equity

Promising Cannabis Stocks To Follow Today - April 1st

Tilray Brands, Quantum Biopharma, RYTHM, Canopy Growth, and Aurora Cannabis are the five Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are publicly...

Tilray Brands Q3 Earnings Call Highlights

Tilray Brands (NASDAQ:TLRY) reported record third-quarter fiscal 2026 revenue and reaffirmed its full-year adjusted EBITDA outlook, as management pointed to accelerating international cannabis...

<ul class="summary-bullets"><li>Tilray’s Q3 cannabis revenue climbed 19%, supported by a sharp 73% surge in international sales.</li><li>The firm’s net loss narrowed significantly to $0.24 per share but fell below Street estimates.</li><li>Tilray reaffirmed its FY2026 EBITDA outlook of $62 - $72 million.</li></ul>Shares of Tilray Brands, Inc. (TLRY) jumped 4% on Wednesday after the company delivered a&nbsp;record&nbsp;third-quarter revenue, fueled by strong momentum in its international cannabis business.Retail sentiment for <a href="https://stocktwits.com/symbol/TLRY">TLRY</a> on Stocktwits turned ‘extremely bullish’ from ‘neutral’ a day earlier, amid ‘high’ message volumes.<img src="https://news.stocktwits-cdn.com/TLRY_jpg_afd9ee6d76.webp" alt="TLRY.jpg"><h2 class="st-heading-2">Tilray Q3 Revenue Beats Street Estimates</h2>Tilray reported an 11% increase in third-quarter (Q3) revenue to $206.7 million, beating Wall Street’s estimates of $201.3 million, according to Fiscal.ai data. Growth was primarily driven by its cannabis and distribution segments.Cannabis revenue climbed 19% to $64.8 million, supported by a sharp 73% jump in international sales. The company’s distribution net revenue, which includes Tilray Pharma, grew 34% to $83 million.Tilray’s net loss narrowed significantly to $25.2 million from $793.5 million a year earlier, while loss per share improved to $0.24 from $8.69. However, this fell short of consensus estimates of $0.14.The company’s balance sheet strengthened, shifting to a net cash position of $3.5 million from a net debt position of $36.6 million last year. Tilray also reaffirmed its full-year 2026 adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) outlook between $62 million and $72 million.<h2 class="st-heading-2">Tilray Bullish On Beverage Segment Despite Revenue Decline</h2>Tilray’s revenue from its beverages business fell around 24% to $42.6 million in Q3, but management remained bullish on international expansion.“With the acquisition of BrewDog, the UK’s leading craft beer brand, and our recently announced partnership with Carlsberg beginning in 2027, we are accelerating the buildout of a scaled global beverage platform. These initiatives broaden our infrastructure, strengthen our brand portfolio, and enhance our distribution capabilities, positioning Tilray to capture growth across key markets in the U.S., Europe, the Middle East, Australia, and Asia-Pacific,” said Irwin D. Simon, Chairman and CEO.Tilray acquired BrewDog in March after signing an exclusive licensing agreement with the Carlsberg Group a month earlier.<h2 class="st-heading-2">What Did Retail Traders Say?</h2>Chatter was mixed. One user said the stock is overdue for an “upside reversal” after the earnings report. The stock has crashed nearly 30% so far this year.<stembedurl>https://stocktwits.com/jeffgosia6/message/649148662</stembedurl>Another user said the revenue beat doesn’t matter since the company is “burning money.”<stembedurl>https://stocktwits.com/SabbyArmistice/message/649157464</stembedurl>Retail investors are also keeping an eye on updates from Washington’s review of the Food and Drug Administration (FDA)’s proposed CBD compliance rule.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/nio-xpev-li-stock-move-march-deliveries-tesla-q1-outlook/cZ7Hk1xRInt">NIO, XPEV, LI Stocks Rally Pre-Market On Delivery Rebound In March – Even As Tesla Braces For Slower Quarter</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Tilray Brands logo is seen displayed on a smartphone and in the background.

TLRY Stock Jumps On Revenue Beat, International Growth – Retail Eyes ‘Upside Reversal’ After 30% Slide This Year

Tilray reported an 11% increase in third-quarter revenue to $206.7 million, beating Wall Street’s estimates of $201.3 million, according to Fiscal.ai data.

Tilray's International Business Surge Sparks Rally — Retail Eyes ‘Upside Reversal’ After 30% Slide This Year

Tilray Brands, Inc. (TLRY) Reports Q3 Loss, Beats Revenue Estimates

Tilray Brands (TLRY) delivered earnings and revenue surprises of -71.43% and +0.39%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?

Why Tilray Brands Shares Are Surging In Wednesday's Premarket

Tilray Brands Inc (TLRY) shares are climbing in Wednesday's premarket as the company prepares to report Q3 fiscal 2026 results.read more...

Tilray Brands (NASDAQ:TLRY) Shares Up 8% - Time to Buy?

Tilray Brands (NASDAQ:TLRY) Trading Up 8% - Should You Buy...

Top Cannabis Stocks To Keep An Eye On - March 31st

Tilray Brands, IM Cannabis, Canopy Growth, Aurora Cannabis, Silver Spike Investment, Quantum Biopharma, and SNDL are the seven Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of publicly traded companies whose primary business relates to the...

Tilray Brands' Q3 Earnings on the Horizon: What's in The Offing?

TLRY heads into Q3 FY26 earnings with projected revenues up 10.9% and narrower losses, but margin pressure in cannabis and beverages clouds the outlook.

$TLRY Q3 &#39;26 Earnings Results &amp; Recap

For its fiscal year ended May 31, 2026, Tilray Brands reconfirms guidance for adjusted EBITDA of $62M to $72M, representing 13% to 31% growth compared to fiscal year 2025.

Stocktwits

Tilray Brands Inc

 Q3 '26 Earnings Results & Recap

For its fiscal year ended May 31, 2026, Tilray Brands reconfirms guidance for adjusted EBITDA of $62M to $72M, representing 13% to 31% growth compared to fiscal year 2025.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Thematic ETFs

Prediction Markets

OpenClaw & Agentic-Directed Trading

Tokenization

Recognizing the tool or mechanism that redefined how we trade. From prediction markets to next-gen tech, this award honors the innovation that pushed the boundaries of access and efficiency in modern finance.

Stocktwits Polls

Investors are debating the Q3 revenue surprise while navigating continued net losses and management skepticism.

Anticipation for cannabis pilot program news and potential S3 scheduling updates is driving sentiment for the upcoming week.

Retail shareholders are calling for leadership changes citing persistent cash burn and unsuccessful diversification into craft beer.

Some bulls are betting that high short interest and forced coverage will spark a massive reversal despite current downtrends.

Tilray Brands is trending as investors react to the company moving up its earnings report to April 1st, fueling intense speculation about potential surprises or major catalysts. The community remains deeply divided, with bulls highlighting beverage expansion deals and upcoming federal CBD Medicare pilot programs, while vocal critics continue to focus on long-standing frustrations regarding share dilution, leadership, and sector-wide volatility.

TLRY
Tilray Brands Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Earnings Recap

Latest TLRY News

TLRYTilray Brands Inc